BrightSpring Health Services’s Q1 Earnings Call: Our Top 5 Analyst Questions
BrightSpring Health Services delivered results in Q1 that surpassed Wall Street’s expectations, with the market responding positively to broad-based growth across both pharmacy and provider services. Management attributed performance to continued momentum in specialty pharmacy and infusion, as well as successful integration of recent acquisitions in home health. CEO Jon Rousseau noted, “We saw really good growth, particularly with the ramp-up of existing limited distribution drugs (LDDs), the la